02.06.26 -- The Metaphoric Rise Of Outsourcing

Developing semi-solid topical drug products from concept to commercialization presents unique formulation and scale-up challenges. This webinar explores how excipient interactions, processing parameters, and equipment differences impact stability, performance, and patient experience. Learn how applying Quality by Design (QbD) principles across development, scale-up, and manufacturing reduces risk and supports reliable, commercially viable products from bench to market success. Click here to learn more.

Developing therapies for rare diseases faces hurdles like high costs, small patient populations, and complex small-batch manufacturing. CDMOs offer crucial support, expertise, and flexibility.

Segments increase press output by up to 25% and cut setup time by 88%. Learn the benefits, drawbacks, and manufacturing needs of this rapidly growing tablet press technology.

Discover five key factors that drive a seamless and efficient technology transfer, highlighting how a culture of technical expertise, customer focus, and operational flexibility is crucial to success.

From regulatory fragmentation to cold chain risks, discover how strategic action, data visibility, and resilient design keep clinical trials on track.

Accurate, readable pharmaceutical labels are crucial. Navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.

Developing a stability-indicating analytical method for a dual-API injectable product requires careful forced degradation studies. Review the robust testing approach that ensured project progression.

Technological developments have led to growth in the suitability of fermentation for a myriad of applications. View the impact of the evolution of synthetic biology and supporting technologies.

Spray drying of amorphous dispersions improves solubility and bioavailability, enabling supersaturation in the intestine and driving higher absorption rates when compared to crystalline drug forms.

Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.

Beyond traditional CDMO services, we at as your strategic partner, delivering customized solutions rooted in a deep understanding of each project to help move your goals forward.

With our specialized support, you can be confident that your ophthalmic drug will not only meet regulatory standards but also address unmet medical needs in the most expedited manner possible.

Learn how the right partner can ensure that your facilities maintain cGMP-compliance and help establish the correct testing program and parameters based on your needs.